Marketing Approval from US FDA for Venlafaxine HCl Tablets
30 / 05 / 2015
May 29, YaoPharma received the marketing approval from US FDA for its ANDA product Venlafaxine HCl Tablets, which means that YaoPharma has the right to sell this product to US market. It opened the gate for YaoPharma to sell finished products to regulated markets and made a firm step to YaoPharma’s internationalization strategy.
Venlafaxine HCl Tablets is a product mainly used for major depressive disorder (ANDA number 202036).
About YAOPHARMA
YaoPharma is a pharmaceutical manufacturer integrating R&D, manufacturing and marketing & sales functions, with multiple subsidiaries, and fully complying with Chinese GMP. Its oral solid line passed GMP inspection from Health Canada and US FDA; its API site passed GMP inspection from US FDA, EU EDQM, Australia TGA and Japan PMDA, etclearn more...
